Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of software and consulting services for pharmaceutical R&D and environmental toxicology, announced that it expects to file its quarterly report on Form 10-Q for the third quarter of its 2012 fiscal year, ended May 31, 2012, with the U.S. Securities and Exchange Commission Wednesday, July 11, 2012. Chairman and Chief Executive Officer Walt Woltosz will host a conference call to discuss the Company’s performance on Thursday, July 12, at 1:15 p.m. PDT/4:15 p.m. EDT.
The conference call will be webcast live and may be accessed by first registering at the following website:
. Upon registering, you will receive a confirmation e-mail with a unique link and instructions for joining the call. Please dial in five to ten minutes prior to the scheduled start time. For listen-only mode, you may dial (415) 363-0078, and enter access code 855-469-584.
About Simulations Plus, Inc.
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation and modeling software, which is licensed to and used in the conduct of drug research by major pharmaceutical, biotechnology, agrochemical, and food industry companies worldwide. Simulations Plus, Inc., is headquartered in Southern California and trades on the NASDAQ Capital Market under the symbol “SLP.” For more information, visit our Web site at